List of companies in Deerfield Management's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease. | ||||||
A biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation | ||||||
Schrodinger is a New York-based company providing software solutions and services for life sciences and materials research. | ||||||
Somatus is a healthcare company that provides integrated care to help patients delay or prevent kidney disease. | ||||||
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies. | ||||||
Generation Bio is a biotechnology company that was founded in 2016 | ||||||
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases. | ||||||
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019. | ||||||
Epic Sciences is a San Diego-based company founded in 2008 by Jorge Nieva, David Nelson and Peter Kuhn. | ||||||
A company focused on mapping and controlling the genes to treat diseases | ||||||
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases | ||||||
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics | ||||||
Frontier Medicines is a biopharmaceutical company developing chemoproteomics for drug discovery founded in 2018. | ||||||
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013. | ||||||
Alector is a San Francisco, California biotechnology company developing treatments for neurodegeneration and cancer through immuno-neurology and immuno-oncology. | ||||||
REGENXBIO is developing gene therapy to improve the lives of people suffering from severe diseases with significant unmet medical need. | ||||||
GrayBug is a pharmaceutical company developing therapies for ocular diseases founded in 2011. | ||||||
Frequency Therapeutics is a small molecules that activate progenitor cells founded in 2015 by David L. Lucchino. | ||||||
Pairwise uses CRISPR, gene editing and natural diversity in agricultural crops to address global food challenges. The company is working to develop new varieties of crops. | ||||||
Xilio Therapeutics is a cancer Immunotherapies founded in 2016 by Rene Russo. | ||||||
RubiconMD is a company founded in 2013 by Julien L. Pham, Gil Addo, Carlos Reines and Gilbert Addo. | ||||||
ESSA Pharma is developing treatments for prostate cancer. | ||||||
Mirum Pharmaceuticals is developing treatments for liver disease. | ||||||
Cohere Health offers a collaboration platform in the health industry. |
